- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6876 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
Patent holdings for IPC class C12Q 1/6876
Total number of patents in this class: 3299
10-year publication summary
117
|
132
|
131
|
278
|
439
|
402
|
466
|
479
|
397
|
302
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
10X Genomics, Inc. | 1018 |
69 |
Illumina, Inc. | 2932 |
64 |
The Regents of the University of California | 19182 |
63 |
President and Fellows of Harvard College | 5838 |
49 |
Becton, Dickinson and Company | 6896 |
39 |
Natera, Inc. | 270 |
38 |
The Board of Trustees of the Leland Stanford Junior University | 6114 |
33 |
Illumina Cambridge Limited | 681 |
31 |
Prognosys Biosciences, Inc. | 95 |
29 |
University of Washington through its Center for Commercialization | 497 |
28 |
Massachusetts Institute of Technology | 9837 |
27 |
Life Technologies Corporation | 3127 |
27 |
Bio-Rad Laboratories, Inc. | 1602 |
27 |
The Johns Hopkins University | 5428 |
26 |
The Broad Institute, Inc. | 1638 |
26 |
Gen-Probe Incorporated | 983 |
24 |
F. Hoffmann-La Roche AG | 7961 |
21 |
Cepheid | 328 |
20 |
Regeneron Pharmaceuticals, Inc. | 3825 |
20 |
Singular Genomics Systems, Inc. | 236 |
20 |
Other owners | 2618 |